Akupunktur i behandling av hetetokter for brystkreftopererte pasienter - en randomisert kontrollert
studie
Engelsk titel: Acupuncture in the treatment of hot flashes in surgically treated breast cancer patients, a
randomized controlled trial
Läs online
Författare:
Hervik, Jill
;
Mjåland, Odd
Email: jill.hervik@siv.no
Språk: Nor
Antal referenser: 25
Dokumenttyp:
RCT
UI-nummer: 10103628
Sammanfattning
Purpose: Acupuncture has been used to treat the problem of hot flashes in healthy postmenopausal
women. The object of this study was to investigate the efficacy of acupuncture
in women with breast cancer suffering from hot flashes as a result of anti-oestrogen
medication.
Method: In a prospective, controlled trial, 59 women suffering from hot flashes following
breast cancer surgery and adjuvant oestrogen-antagonist treatment (Tamoxifen) were randomized
to either 10 weeks of traditional Chinese acupuncture or sham acupuncture (SA).
Mean number of hot flashes at day and night were recorded prior to treatment, during the
treatment period as well as during the 12 weeks following treatment. A validated health
score (Kupperman index) was conducted at baseline, at the end of the treatment period and
at 12 weeks following treatment.
Result: During the treatment period mean number of hot flashes at day and night was
significantly reduced by 50 and almost 60%, respectively from baseline in the acupuncture
group, and was further reduced by 30% both at day and night during the next 12 weeks. In
the sham acupuncture group a significant reduction of 25% in hot flashes at day was seen
during treatment, but was reversed during the following 12 weeks. No reduction was seen
in hot flashes at night. Kupperman index was reduced by 44% from baseline to the end
of the treatment period in the acupuncture group, and largely maintained 12 weeks after
treatment ended. No corresponding changes were seen in the sham acupuncture group.
Conclusion: Acupuncture seems to provide effective relief from hot flashes both day and
night in women operated for breast cancer, treated with Tamoxifen. This treatment effect
seems to coincide with a general health improvement measured with the validated Kupperman
index.